https://www.selleckchem.com/pr....oducts/oxythiamine-c
Most stage 2 participants were classified as stage 2 because of abnormal ΔOBJ only (44-59%), whereas 11 to 21% had SCD only, and 9 to 13% had ΔNBS only. Short-term stability varied by stage and OBJ cutoff points but the most notable changes were seen in stage 2 with 38 to 63% remaining stable, 4 to 13% worsening, and 24 to 41% improving (moving to stage 1). The frequency of the stages varied by age and the precise membership fluctuated by the parameters used to define the stages. The staging framework may requ
Beğen
Yorum Yap
Paylaş
